News Home Page
Access the 15 most recent news items below. For older items, please click the 'view archives' link in the lower right.
Aquaro Biosystems' Pacesetter Section Mounting System Enables Hands-Free Operation
Aquaro Biosystems introduced its PaceSetter section mounting system, a product developed to streamline the histology workflow, at the National Society for Histotechnology Annual Convention in Austin, Texas. The PaceSetter is the first benchtop instrument to automate the transfer of paraffin-embedded tissue sections directly from microtomes to glass slides.The PaceSetter section mounting system, which attaches directly and easily to microtomes, uses a water channel to gently transfer sections to glass ...
Posted on: September 17, 2014
Human Brain Deficits of PKCe: Targeted for Alzheimer's Disease Diagnostic and Therapeutic Trials
Researchers at the Blanchette Rockefeller Neurosciences Institute (BRNI) recently announced findings from a new study entitled, "PKCe Deficits in Alzheimer's Disease Brains and Skin Fibroblasts." These new findings offer significant promise for a new therapeutic and diagnostic approach to Alzheimer's disease (AD) that has remained so refractory to effective and early drug treatment. This approach is now the major focus of ongoing clinical trials being conducted by at BRNI/Neurotrope Inc. ...
Posted on: September 17, 2014
METTLER TOLEDO's XPE205 Analytical Laboratory Balance Wins 2014 R&D 100 Award
METTLER TOLEDO has been awarded the coveted "R&D 100 Award" for the XPE205 Analytical Laboratory Balance, focused on providing users with a high level of process security while making working processes as ergonomic and efficient as possible.The prestigious R&D 100 Awards have taken place for 52 years, helping companies provide the important initial push a new product needs to compete successfully in the marketplace. Winning an R&D 100 Award provides a mark of excellence known to industry, ...
Posted on: September 16, 2014
Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Study
A novel biomarker for rheumatoid arthritis has significant potential to help physicians better identify early stage disease, when treatment can often arrest further disease progression and disability, according to a new study published in The Journal of Rheumatology.Researchers found that elevated levels of the 14-3-3eta protein outperformed conventional antibody testing, including rheumatoid factor (RF) alone and anti-citrullinated peptide antibodies alone (ACPA, also known as antibodies to cyclic ...
Posted on: September 15, 2014
A Blood Test for Suicide?
Johns Hopkins researchers say they have discovered a chemical alteration in a single human gene linked to stress reactions that, if confirmed in larger studies, could give doctors a simple blood test to reliably predict a person's risk of attempting suicide.The discovery, described online in The American Journal of Psychiatry, suggests that changes in a gene involved in the function of the brain's response to stress hormones plays a significant role in turning what might otherwise be an unremarkable ...
Posted on: September 12, 2014
QIAGEN Adds Genomic Biomarkers for Assessing Prognosis In Treatment of Blood Cancers
QIAGEN N.V. has acquired an exclusive global license to the biomarker SF3B1 from the University of Tokyo. SF3B1 is believed to play a critical role in the prognosis of patients with myelodysplastic syndromes (MDS), a group of hematological cancers in which bone marrow does not produce enough healthy blood cells. Mutations of this gene, which is an important component of the spliceosome machinery, indicate a more favorable disease progression for patients than the "wild-type" gene, so testing for these ...
Posted on: September 11, 2014
University of California Irvine Medical Center Deploys the Performance Insight Dashboard from Visiun
Visiun has announcess the installation of the Performance Insight Dashboard at the laboratories of the University of California Irvine Medical Center located in Orange, Calif.For the past 13 years, UC Irvine Medical Center has been ranked among the country's best hospitals by the U.S. News & World Record and is currently ranked number one in Orange County, emphasizing their commitment to bring personalized and leading-edge care to their community. Being the only university-based medical center in ...
Posted on: September 10, 2014
AACC Calls for Abstracts for Virtual Conference
An opportunity is at hand to be a part of Personalized Diagnostics Today, AACC's inaugural virtual conference (completely online and free to AACC members) by submitting an abstract. Investigators are encouraged to submit abstracts in all areas of omics-based study that relate to facilitating or providing personalized medicine.If your abstract is accepted you will be asked to develop a PDF poster of your work for viewing by conference participants in a virtual poster hall on the live days of ...
Posted on: September 09, 2014
Insight Genetics Adds Six New Team Members
Insight Genetics Inc., a molecular diagnostic company dedicated to improving the lives of cancer patients through advanced diagnostics, announced today that it has added six employees to its team, growing its expertise in scientific research and development and quality assurance. As a Scientist II, Rebecca Smith, PhD, will use her experience in molecular genetics to support the Insight Genetics Research & Development team in late phase projects for transition to clinical use. Prior to Insight ...
Posted on: September 08, 2014
PerkinElmer Debuts New Microplates for Higher Quality Results in High Content Screening
PerkinElmer Inc., a global leader focused on the health and safety of people and the environment, has launched its CellCarrier Ultra 384-well microplates, designed specifically for high content screening (HCS). The improved plate design results in higher quality image data and more robust results from HCS applications (such as phenotypic screening and three-dimensional disease model studies). This combination of capabilities provides researchers with the ability to obtain greater ...
Posted on: September 08, 2014
Ventana Paves the Way for Companion Diagnostic Early Phase Clinical Trials in China
Ventana Medical Systems Inc., a member of the Roche Group, has announced a new agreement with Quintiles Inc. to offer College of American Pathology (CAP)-standard companion diagnostic testing services in China for pharmaceutical and biotech companies conducting early phase clinical trials. This is great news for patients as China is one of the only countries in the world that requires all patient samples be tested in China, even those used in clinical trials.According to the World Health Organization's ...
Posted on: September 07, 2014
Protagen AG Launches Landmark First Research Test Kit for Systemic Sclerosis
Protagen AG, a company dedicated to the development of powerful diagnostic tools to address some of the most severe autoimmune diseases, has today launched its first ELISA research use test kit for Systemic Sclerosis (SSc), the ADxSSc Multilisa. Protagen developed the new assay to synergistically combine two proprietary, novel disease markers with two standard diagnostic markers to support medical research in autoimmune diseases. Systemic sclerosis is one of a number of complex autoimmune ...
Posted on: September 05, 2014
Definiens to Host the First International Symposium for Tissue Phenomics This Fall
Founder, and Chief Technology Officer, Definiens Definiens to Host the First International Symposium for Tissue Phenomics This FallDefiniens, global leader in Tissue Phenomics for oncology diagnostics, is accepting registrations for the company's inaugural conference, The International Symposium for Tissue Phenomics. Alongside genomics, Tissue Phenomics is a key driver in the growth of personalized medicine, and the symposium brings together thought leaders from around the globe on ...
Posted on: September 04, 2014
Two More States Begin Implementation of SCID Newborn Screening
The Immune Deficiency Foundation (IDF) commends the states of Maine and Rhode Island for adding Severe Combined Immune Deficiency (SCID) to their states' newborn screening panels. These states join 21 other states currently screening newborns for SCID, ensuring over two thirds of all babies in the U.S. are now being screened. SCID is a type of primary immunodeficiency disease where affected infants lack the T-cells and antibody immunity that help fight infections from a wide array of viruses, bacteria and ...
Posted on: September 03, 2014
CLSI Releases New Microbiology Standard for Detection of Anaerobes in Clinical Specimens
The Clinical and Laboratory Standards Institute (CLSI) released a new microbiology standard, Principles and Procedures for Detection of Anaerobes in Clinical Specimens; Approved Guideline (M56-A). This document presents standardized, cost-effective, and efficient best practice processes for anaerobe bacteriology to assist clinical laboratories in selecting those methods that lead to improved patient care. "M56-A is an up-to-date manual for anaerobic bacteriology written to guide the ...
Posted on: September 02, 2014